# Clinical Notes System — Compliance Readiness Assessment (Engineering Perspective)

## What this document is, and is not

**This is not a legal compliance certification, and it does not constitute legal advice.** It is an engineering-perspective inventory of what the audited system technically does today with respect to sensitive health data, written so that qualified legal/compliance counsel has a concrete starting point rather than a blank page. Every claim about the system's current behavior is grounded in the reverse-engineering audit (`reports/clinical-note-audit/00`–`16`) already performed on this codebase. Every claim about applicable law is offered as general, publicly-known regulatory context, not as a verified legal determination — actual applicability, scope, and compliance status must be confirmed by qualified counsel.

**Why this document exists**: the implementation plan (`reports/clinical-notes-implementation-plan.md`) identified compliance as the single largest unaddressed gap across nineteen prior reports — none of them touched it. This document does not close that gap; it defines its shape so it can be closed by the right people.

**Note on prior material**: a file named `documents/01-COMPLIANCE_TANZANIA_HEALTHCARE_2026.md` existed in this repository and shows as a pending, uncommitted deletion in git status as of this engagement. Its content was not reviewed in producing this document (per explicit instruction, it was neither restored nor consulted) — this is a fresh assessment, not a continuation of that file, and may therefore duplicate or diverge from whatever it contained.

---

## 1. Regulatory context (general knowledge, not a legal determination)

The system's test/seed fixtures throughout the codebase use `country_code: 'TZ'` and Tanzanian addressing conventions, suggesting the deployment context is Tanzania. If accurate, the primary data-protection framework likely to apply is:

- **The Personal Data Protection Act, 2022 (Tanzania)** and its implementing regulations, administered by the Personal Data Protection Commission — Tanzania's general-purpose data protection law, applicable to processing of personal data, with health data typically treated as a special/sensitive category attracting heightened obligations (lawful basis, purpose limitation, data subject rights, breach notification, and rules on cross-border transfer).
- **Sector-specific Ministry of Health regulations or guidelines** on medical record-keeping, retention periods, and clinician documentation standards, which may impose requirements independent of general data protection law (e.g., minimum retention periods for clinical records, requirements for who may sign/amend a record).
- If this system is ever deployed to or accessed from other jurisdictions, additional frameworks (e.g., a facility with US-based operations invoking HIPAA, or EU-connected data flows invoking GDPR) could also apply — **this has not been assessed and requires an explicit scoping question: in which jurisdictions does this system actually operate or store data?**

**This section is deliberately general.** Confirming which of these actually apply, and what they specifically require, is exactly the work a qualified compliance/legal reviewer needs to do — this document does not substitute for that.

---

## 2. What sensitive data this system actually handles (grounded in the audit)

Per `clinical-note-audit/09-database-structure.md` and the Patient/Pharmacy modules referenced throughout: patient demographics (name, date of birth, gender, phone, national ID field, address), free-text clinical narrative (subjective/objective/assessment/plan), structured diagnosis codes, medication orders and allergy records, lab/radiology order and result data, and an append-only history of who changed what and when. This is health data by any reasonable definition, in any jurisdiction's framework — it should be treated as a special/sensitive category requiring the highest handling standard the applicable law provides, pending confirmation of which law that is.

---

## 3. Technical safeguards already in place (confirmed by the audit)

| Safeguard | Status | Source |
|---|---|---|
| Append-only clinical audit trail (who/what/when for every note and encounter change) | **Present** — `medical_record_audit_logs`, `encounter_audit_logs`, both with actor, action, changes, metadata, timestamp | `clinical-note-audit/09` §9.3, §9.7 |
| Tenant/facility data isolation | **Present** — `CurrentPlatformScopeContextInterface`, `EnforceTenantIsolationWhenEnabled` middleware, applied to every audited write path | `clinical-note-audit/07` §7.1 |
| Access control on every endpoint | **Present, but architecturally thin** — every endpoint requires a permission string via `->can()`, but no `Policy` classes or `Gate::define()` registrations were found, and the source of permission-string registration was never located | `clinical-note-audit/08` §8.6 |
| Signer attestation for finalized notes | **Present** — a dedicated `medical_record_signer_attestations` table, separate from the status field itself | `clinical-note-audit/09` §9.4 |
| Separation of clinical audit trail from system/diagnostic logging | **Present** — deliberately enforced when the canonical-state Shadow Mode logging was added, so diagnostic noise never mixes with the clinical audit trail | `encounter-state-machine-design/01` §4.1 |

---

## 4. Gaps a real compliance review would need to examine

None of these are asserted as violations — they are things the audit found **absent or unverified**, which is exactly what a compliance review needs to check:

- **Data retention and deletion policy**: no soft-delete mechanism, retention period, or deletion/purge process was found on any of the seven core clinical tables (`clinical-note-audit/09` §9.11). If law or policy requires either a minimum retention period or a right-to-erasure mechanism, neither currently has a technical implementation to point to.
- **Encryption at rest / in transit**: out of scope of the prior audit entirely — nothing in the 19 reports confirms or denies database-level encryption, backup encryption, or TLS enforcement. This needs a dedicated infrastructure-level review, not just an application-code review.
- **Patient consent management**: no consent-capture or consent-withdrawal mechanism was found anywhere in the audited MedicalRecord/Encounter/Patient modules.
- **Data subject rights (access, portability, correction, erasure)**: no API or workflow for a patient to request their own data, request correction, or request deletion was found. The existing `medical_record_versions` table actually preserves *every* historical version of a note — which is good for clinical audit integrity but is in direct tension with any "right to erasure" requirement, and reconciling the two is a real, unresolved design question, not a simple toggle.
- **Breach notification procedure**: nothing found; this is an organizational/operational process question as much as a technical one.
- **Data integrity risks with compliance relevance**: several of the sixteen findings in `clinical-note-audit/15` are directly compliance-relevant even though they were originally framed as clinical-safety risks — a duplicate encounter (C-4) or a stale signature displayed as authentic (C-3) both mean the system could, in the current state, produce or display a legal medical record that misrepresents what actually happened. A compliance reviewer should treat the critical-severity findings in that report as inputs to their own risk assessment, not just an engineering backlog.
- **Cross-border data transfer**: unassessed — depends entirely on where the database, backups, and any third-party services (e.g., the Billing module's dependencies) actually run.
- **Staff/role training and organizational policy**: entirely outside this system's code and therefore outside anything the 19 prior reports could have found — a technical audit cannot confirm whether staff are trained on data handling obligations.

---

## 5. Recommended next step

Engage qualified legal/compliance counsel with specific expertise in Tanzania's Personal Data Protection Act, 2022 (and any applicable Ministry of Health record-keeping regulations), and give them this document plus the full `clinical-note-audit/` and `encounter-state-machine-design/` report sets as the technical starting point. The most urgent scoping question for that engagement: **confirm the actual deployment jurisdiction(s) and hosting arrangement**, since every recommendation above depends on getting that right first. This document does not answer that question — it can only be answered by whoever operates this system in production.
